EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Foxp3+/ CD4 + Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases

Andriy Trailin iD, Esraa Ali, Sergii Pavlov, Wenjing Ye iD, Lenka Červenková, Ondřej Vyčítal, Filip Ambrozkiewicz, Miroslav Jiřík, Ondřej Daum, Václav Liška, Kari Hemminki

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.71989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 29.05.2026. Verfasst von Andriy Trailin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Hauptthemen laut MEDLINE: Liver Neoplasms, Forkhead Transcription Factors, Colorectal Neoplasms, CD4-Positive T-Lymphocytes. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentura Pro Zdravotnický Výzkum České Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to assess the abundance, distribution, and prognostic significance of Foxp3+ and CD4+ T‐cells and their ratio in primary colorectal cancer (pCRC) and liver metastases (LM) in patients with synchronous and metachronous disease.

Methods

We performed a retrospective study involving patients who underwent resections of both pCRC and either synchronous ( N = 55) or metachronous LM ( N = 44). Following sequential immunohistochemical staining for CD4+ and Foxp3+ T‐cells, whole‐slide scans were analyzed using QuPath software to quantify T‐cells in the tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of both pCRC and LM. T‐cell densities and their ratios were tested as prognostic variables for disease‐free survival (DFS) and time to recurrence (TTR).

Results

We found greater densities of CD4+ cells in OM and PT of LM of synchronous and metachronous patients compared to pCRC. In both groups, densities of Foxp3+ cells were higher in all regions of interest of pCRC compared to LM. CD4+ cells were more abundant than Foxp3+ cells in IM, OM, and PT of LM; densities of Foxp3+ cells were higher in TC and IM of pCRC. Neither CD4+ nor Foxp3+ cells in pCRC were individually predictive of survival, but a higher Foxp3+/CD4+ cells ratio in OM of pCRC in the metachronous group was associated with shorter DFS (hazard ratio (HR): 2.34, 95% confidence interval (CI): 1.14–4.79, p = 0.02) and TTR. Conversely, in OM and PT of pCRC in the synchronous group, a higher ratio was associated with longer DFS (HR: 0.53, CI: 0.29–0.98, p = 0.04 and HR: 0.46, CI: 0.25–0.86, p = 0.02, respectively) and TTR.

Conclusions

The high Foxp3+/CD4+ cells ratio was associated with shorter survival in metachronous and longer survival in synchronous disease, providing novel clinical implications. Foxp3+/CD4+ cells ratio in pCRC may help better stratify CRC patients with synchronous LM after resection of the primary tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsForkhead Transcription FactorsColorectal NeoplasmsCD4-Positive T-LymphocytesHumansFemaleMalePrognosisMiddle AgedAgedRetrospective StudiesAdultAged, 80 and over

Stichwörter der Autor:innen

Foxp3+/CD4+ cells ratiocolorectal cancersurvivalsynchronous and metachronous liver metastasestumor‐infiltrating lymphocytes

Substanzen

Forkhead Transcription FactorsFOXP3 protein, human

Autor:innen und Institutionen

  • Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • NTIS, University of West Bohemia, Pilsen, Czech Republic.
  • Sikl's Institute of Pathology, Faculty of Medicine and Teaching Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Bioptická Laboratoř s.r.o., Pilsen, Czech Republic.

ORCID-Profile: Andriy Trailin, Wenjing Ye

Förderung

  • Agentura Pro Zdravotnický Výzkum České Republiky

Zitieren

APA

Trailin, A., Ali, E., Pavlov, S., Ye, W., Červenková, L., Vyčítal, O., Ambrozkiewicz, F., Jiřík, M., Daum, O., Liška, V., & Hemminki, K. (2026). Foxp3+/ CD4 + Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71989

Vancouver

Trailin A, Ali E, Pavlov S, Ye W, Červenková L, Vyčítal O, et al. Foxp3+/ CD4 + Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71989

BibTeX
@article{Trailin2026,
  author = {Trailin, Andriy and Ali, Esraa and Pavlov, Sergii and Ye, Wenjing and Červenková, Lenka and Vyčítal, Ondřej and Ambrozkiewicz, Filip and Jiřík, Miroslav and Daum, Ondřej and Liška, Václav and Hemminki, Kari},
  title = {Foxp3+/ CD4 + Cell Ratio in Primary Colorectal Cancer Predicts Opposite Prognoses Following Resection of Synchronous or Metachronous Liver Metastases},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.71989}
}
Kostenlos starten →